JOHNSON & JOHNSON — Director's Dealing 2014

Nov 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEVRO CORP (NVRO)
CIK: 0001444380
Period of Report: 2014-11-12

Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-12	Common Stock	C	3037005	—	Acquired	3037005	Indirect
2014-11-12	Common Stock	P	40000	$18.00	Acquired	3077005	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-12	Series B Convertible Preferred Stock	$	C	2790178	Disposed		Common Stock (2790178)	Indirect
2014-11-12	Series C Convertible Preferred Stock	$	C	246827	Disposed		Common Stock (246827)	Indirect

Footnotes

F1: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.

F2: Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional consideration. There was no expiration applicable to the Preferred Stock.